Brief: Genetron Health And Fosun Pharma Announce Exclusive Partnership To Commercialize SEQ-MRD In China
22/10/2021 12:24
Oct 22 (Reuters) - Genetron Holdings Ltd GTH.O :
* GENETRON HEALTH AND FOSUN PHARMA ANNOUNCE EXCLUSIVE
PARTNERSHIP
TO COMMERCIALIZE SEQ-MRD® IN CHINA
* GENETRON HOLDINGS LTD - CO AND JIANGSU FOSUN PHARMA
INTEND TO
SERVE PATIENTS AFFLICTED BY LYMPHOID MALIGNANCIES
Source text for Eikon: ID:nGNX78jNQJ
Further company coverage: GTH.O
Recent news on Genetron Holdings
See all newsBrief: Genetron Holdings Requested That Trading Of Its ADSs On Nasdaq Be Suspended As Of Close Of Trading On March 28, 2024
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius
U.S. STOCKS ON THE MOVE-Scholar Rock, Target, LL Flooring
U.S. STOCKS ON THE MOVE-First Solar, Genetron, Viasat
Genetron surges on $126 mln deal to go private